Skip to main content
Top
Published in: Journal of Nephrology 2/2017

01-04-2017 | Original Article

Healthcare costs of the progression of chronic kidney disease and different dialysis techniques estimated through administrative database analysis

Authors: Alessandro Roggeri, Daniela Paola Roggeri, Carlo Zocchetti, Maurizio Bersani, Ferruccio Conte, ReNe (Renal Lombardy Network), Additional contributors from ReNe Network

Published in: Journal of Nephrology | Issue 2/2017

Login to get access

Abstract

Background

Chronic kidney disease (CKD) progression is associated with significant comorbidities and costs. In Italy, limited evidence of healthcare resource consumption and costs is available. We therefore aimed to investigate the direct healthcare costs in charge to the Lombardy Regional Health Service (RHS) for the treatment of CKD patients in the first year after starting hemodialysis and in the 2 years prior to dialysis.

Methods

Citizens resident in the Lombardy Region (Italy) who initiated dialysis in the year 2011 (Jan 1 to Dec 31) were selected and data were extracted from Lombardy Regional databases on their direct healthcare costs in the first year after starting dialysis and in the 2 years prior to it was analyzed. Drugs, hospitalizations, diagnostic procedures and outpatient costs covered by RHS were estimated. Patients treated for acute kidney injury, or who died or stopped dialysis during the observational period were excluded.

Results

From the regional population (>9,700,000 inhabitants), 1067 patients (34.3 % females) initiating dialysis were identified, of whom 82 % underwent only hemodialysis (HD), 13 % only peritoneal dialysis (PD) and the remaining 5 % both treatments. Direct healthcare costs/patient were € 5239, € 12,303 and € 38,821 (€ 40,132 for HD vs. € 30,444 for PD patients) for the periods 24–12 months pre-dialysis, 12–0 months pre-dialysis, and in the first year of dialysis, respectively.

Conclusions

This study highlights a significant economic burden related to CKD and an increase in direct healthcare costs associated with the start of dialysis, pointing to the importance of prevention programs and early diagnosis.
Literature
2.
go back to reference Couser WG, Remuzzi G, Mendis S, Tonelli M (2011) The contribution of chronic kidney disease to the global burden of major non communicable diseases. Kidney Int 80(12):1258–1270. doi:10.1038/ki.2011.368 Epub 2011 Oct 12 CrossRefPubMed Couser WG, Remuzzi G, Mendis S, Tonelli M (2011) The contribution of chronic kidney disease to the global burden of major non communicable diseases. Kidney Int 80(12):1258–1270. doi:10.​1038/​ki.​2011.​368 Epub 2011 Oct 12 CrossRefPubMed
3.
go back to reference Levey AS, Astor BC, Stevens LA et al (2010) Chronic kidney disease, diabetes, and hypertension: what’s in a name? Kidney Int 78:19–22CrossRefPubMed Levey AS, Astor BC, Stevens LA et al (2010) Chronic kidney disease, diabetes, and hypertension: what’s in a name? Kidney Int 78:19–22CrossRefPubMed
4.
go back to reference Keith DS, Nichols GA, Gullion CM et al (2004) Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med 164:659–663CrossRefPubMed Keith DS, Nichols GA, Gullion CM et al (2004) Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med 164:659–663CrossRefPubMed
5.
go back to reference Wen CP, Cheng TY, Tsai MK et al (2008) All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462,293 adults in Taiwan. Lancet 371:2173–2182CrossRefPubMed Wen CP, Cheng TY, Tsai MK et al (2008) All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462,293 adults in Taiwan. Lancet 371:2173–2182CrossRefPubMed
6.
go back to reference Eriksen BO, Ingebretsen OC (2006) The progression of chronic kidney disease: a 10-year population-based study of the effects of gender and age. Kidney Int 69:375–382CrossRefPubMed Eriksen BO, Ingebretsen OC (2006) The progression of chronic kidney disease: a 10-year population-based study of the effects of gender and age. Kidney Int 69:375–382CrossRefPubMed
7.
go back to reference Levey AS, Atkins R, Coresh J et al (2007) Chronic kidney disease as a global public health problem: approaches and initiatives—a position statement from Kidney Disease Improving Global Outcomes. Kidney Int 72:247–259CrossRefPubMed Levey AS, Atkins R, Coresh J et al (2007) Chronic kidney disease as a global public health problem: approaches and initiatives—a position statement from Kidney Disease Improving Global Outcomes. Kidney Int 72:247–259CrossRefPubMed
8.
go back to reference Pontoriero G, Pozzoni P, Vecchio LD et al (2007) International Study of Health Care Organization and Financing for renal replacement therapy in Italy: an evolving reality. Int J Health Care Finance Econ 7:201–215CrossRefPubMed Pontoriero G, Pozzoni P, Vecchio LD et al (2007) International Study of Health Care Organization and Financing for renal replacement therapy in Italy: an evolving reality. Int J Health Care Finance Econ 7:201–215CrossRefPubMed
9.
go back to reference Roggeri DP, Roggeri A, and Salomone M (2014) Chronic kidney disease: evolution of healthcare costs and resource consumption from predialysis to dialysis in Piedmont Region, Italy. Adv Nephrol 2014, Article ID 680737, 6 pages. doi:10.1155/2014/680737 Roggeri DP, Roggeri A, and Salomone M (2014) Chronic kidney disease: evolution of healthcare costs and resource consumption from predialysis to dialysis in Piedmont Region, Italy. Adv Nephrol 2014, Article ID 680737, 6 pages. doi:10.​1155/​2014/​680737
10.
go back to reference Cicchetti A, Ruggeri M, Codella P, Ridolfi A (2011) I costi socio-sanitari dell’insufficienza renale cronica. Farmeconomia e Percorsi Terapeutici 12(1):21–28CrossRef Cicchetti A, Ruggeri M, Codella P, Ridolfi A (2011) I costi socio-sanitari dell’insufficienza renale cronica. Farmeconomia e Percorsi Terapeutici 12(1):21–28CrossRef
11.
go back to reference International Classification of Diseases (ICD) (1978) 9th Revision, Basic Tabulation List with Alphabetic Index. World Health Organization, Geneva International Classification of Diseases (ICD) (1978) 9th Revision, Basic Tabulation List with Alphabetic Index. World Health Organization, Geneva
13.
go back to reference Zoccali C, Kramer A, Jager KJ (2010) Chronic kidney disease and end-stage renal disease—a review produced to contribute to the report ‘the status of health in the European union: towards a healthier Europe’. NDT Plus 3(213–312):224 Zoccali C, Kramer A, Jager KJ (2010) Chronic kidney disease and end-stage renal disease—a review produced to contribute to the report ‘the status of health in the European union: towards a healthier Europe’. NDT Plus 3(213–312):224
14.
go back to reference Gorodetskaya I, Zenios S, McCulloch CE et al (2005) Health-related quality of life and estimates of utility in chronic kidney disease. Kidney Int 68:2801–2808CrossRefPubMed Gorodetskaya I, Zenios S, McCulloch CE et al (2005) Health-related quality of life and estimates of utility in chronic kidney disease. Kidney Int 68:2801–2808CrossRefPubMed
15.
go back to reference Kimmel PL, Patel SS (2006) Quality of life in patients with chronic kidney disease: focus on end-stage renal disease treated with hemodialysis. Semin Nephrol 26:68–79CrossRefPubMed Kimmel PL, Patel SS (2006) Quality of life in patients with chronic kidney disease: focus on end-stage renal disease treated with hemodialysis. Semin Nephrol 26:68–79CrossRefPubMed
16.
go back to reference Schieppati A, Remuzzi G (2005) Chronic renal diseases as a public health problem: epidemiology, social, and economic implications. Kidney Int 68(Supplement 98):S7–S10CrossRef Schieppati A, Remuzzi G (2005) Chronic renal diseases as a public health problem: epidemiology, social, and economic implications. Kidney Int 68(Supplement 98):S7–S10CrossRef
17.
go back to reference Global Burden of Disease Study (2013) Collaborators (2015) Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 386(9995):743–800. doi:10.1016/S0140-6736(15)60692-4 Global Burden of Disease Study (2013) Collaborators (2015) Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 386(9995):743–800. doi:10.​1016/​S0140-6736(15)60692-4
18.
go back to reference St. Peter WL, Khan SS, Ebben JP et al (2004) Chronic kidney disease: the distribution of health care dollars. Kidney Int 66:313–321CrossRefPubMed St. Peter WL, Khan SS, Ebben JP et al (2004) Chronic kidney disease: the distribution of health care dollars. Kidney Int 66:313–321CrossRefPubMed
19.
go back to reference Salonen T, Reina T, Oksa H et al (2003) Cost analysis of renal replacement therapies in Finland. Am J Kidney Dis 42(6):1228–1238CrossRefPubMed Salonen T, Reina T, Oksa H et al (2003) Cost analysis of renal replacement therapies in Finland. Am J Kidney Dis 42(6):1228–1238CrossRefPubMed
20.
go back to reference Coentrão LA, Araújo CS, Ribeiro CA et al (2013) Cost analysis of hemodialysis and peritoneal dialysis access in incident dialysis patients. Perit Dial Int 33(6):662–670CrossRefPubMedPubMedCentral Coentrão LA, Araújo CS, Ribeiro CA et al (2013) Cost analysis of hemodialysis and peritoneal dialysis access in incident dialysis patients. Perit Dial Int 33(6):662–670CrossRefPubMedPubMedCentral
21.
go back to reference Karopadi AN, Mason G, Rettore E et al (2013) Cost of peritoneal dialysis and haemodialysis across the world. Nephrol Dial Transplant 28(10):2553–2569CrossRefPubMed Karopadi AN, Mason G, Rettore E et al (2013) Cost of peritoneal dialysis and haemodialysis across the world. Nephrol Dial Transplant 28(10):2553–2569CrossRefPubMed
22.
go back to reference Liu FX, Quock TP, Burkart J et al (2013) Economic evaluations of peritoneal dialysis and hemodialysis: 2004–2012. F1000Research 2:273 Liu FX, Quock TP, Burkart J et al (2013) Economic evaluations of peritoneal dialysis and hemodialysis: 2004–2012. F1000Research 2:273
23.
go back to reference Just PM, Riella MC, Tschosik EA et al (2008) Economic evaluations of dialysis treatment modalities. Health Policy 86(2–3):163–180CrossRefPubMed Just PM, Riella MC, Tschosik EA et al (2008) Economic evaluations of dialysis treatment modalities. Health Policy 86(2–3):163–180CrossRefPubMed
24.
go back to reference Li B, Cairns JA, Fotheringham J et al (2015) Understanding cost of care for patients on renal replacement therapy: looking beyond fixed tariffs. Nephrol Dial Transplant 30(10):1726–1734. doi:10.1093/ndt/gfv224 CrossRefPubMed Li B, Cairns JA, Fotheringham J et al (2015) Understanding cost of care for patients on renal replacement therapy: looking beyond fixed tariffs. Nephrol Dial Transplant 30(10):1726–1734. doi:10.​1093/​ndt/​gfv224 CrossRefPubMed
25.
go back to reference Haut ER, Pronovost PJ, Schneider EB (2012) Limitations of administrative databases. JAMA 307(24):2589–2590CrossRefPubMed Haut ER, Pronovost PJ, Schneider EB (2012) Limitations of administrative databases. JAMA 307(24):2589–2590CrossRefPubMed
26.
go back to reference Schneeweiss S, Avorn J (2005) A review of uses of healthcare utilization databases for epidemiologic research on therapeutics. J Clin Epidemiol 58(4):323–337CrossRefPubMed Schneeweiss S, Avorn J (2005) A review of uses of healthcare utilization databases for epidemiologic research on therapeutics. J Clin Epidemiol 58(4):323–337CrossRefPubMed
27.
go back to reference Harpe SE (2009) Using secondary data sources for pharmacoepidemiology and outcomes research. Pharmacotherapy 29(2):138–153CrossRefPubMed Harpe SE (2009) Using secondary data sources for pharmacoepidemiology and outcomes research. Pharmacotherapy 29(2):138–153CrossRefPubMed
28.
go back to reference National Kidney Foundation (2002) K/DOQI Clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis 39(suppl 1):S1–S266 National Kidney Foundation (2002) K/DOQI Clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis 39(suppl 1):S1–S266
Metadata
Title
Healthcare costs of the progression of chronic kidney disease and different dialysis techniques estimated through administrative database analysis
Authors
Alessandro Roggeri
Daniela Paola Roggeri
Carlo Zocchetti
Maurizio Bersani
Ferruccio Conte
ReNe (Renal Lombardy Network)
Additional contributors from ReNe Network
Publication date
01-04-2017
Publisher
Springer International Publishing
Published in
Journal of Nephrology / Issue 2/2017
Print ISSN: 1121-8428
Electronic ISSN: 1724-6059
DOI
https://doi.org/10.1007/s40620-016-0291-8

Other articles of this Issue 2/2017

Journal of Nephrology 2/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine